Skip Navigation


NDT Advance Access originally published online on April 1, 2007
Nephrology Dialysis Transplantation 2007 22(7):1882-1890; doi:10.1093/ndt/gfm145
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/7/1882    most recent
gfm145v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mezzano, S.
Right arrow Articles by Egido, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mezzano, S.
Right arrow Articles by Egido, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis

Sergio Mezzano1, Alejandra Droguett1, M. Eugenia Burgos1, Claudio Aros1, Leopoldo Ardiles1, Claudio Flores1, Daniel Carpio1, Gisselle Carvajal1, Marta Ruiz-Ortega2 and Jesús Egido2

1Division of Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile and 2Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain

Correspondence and offprint requests to: Sergio Mezzano, MD, Division Nephrology, School of Medicine, Universidad Austral, Valdivia, Chile. Email: smezzano{at}uach.cl



  Abstract

Background. Recent evidence in vitro and in vivo suggests that gremlin, a bone morphogenetic protein antagonist, is participating in tubular epithelial mesenchymal transition (EMT) in diabetic nephropathy as a downstream mediator of TGF-ß. Since EMT also occurs in parietal epithelial glomerular cells (PECs) leading to crescent formation, we hypothesized that gremlin could participate in this process. With this aim we studied its expression in 30 renal biopsies of patients with pauci-immune crescentic nephritis.

Methods. Gremlin was detected by in situ hybridization (ISH) and immunohistochemistry (IMH) and TGF-ß by ISH and Smads by southwestern histochemistry (SWH). Phosphorylated Smad2, CTGF, BMP-7, PCNA, {alpha}-SMA, synaptopodin, CD-68, and phenotypic markers of PECs (cytokeratin, E-cadherin), were detected by IMH. In cultured human monocytes, gremlin and CTGF induction by TGF-ß was studied by western blot.

Results. We observed strong expression of gremlin mRNA and protein in cellular and fibrocellular crescents corresponding to proliferating PECs and monocytes, in co-localization with TGF-ß. A marked over-expression of gremlin was also observed in tubular and infiltrating interstitial cells, correlating with tubulointerstitial fibrosis (r = 0.59; P < 0.01). A nuclear Smad activation in the same tubular cells, that are expressing TGF-ß and gremlin, was detected. In human cultured monocytes, TGF-ß induced gremlin production while CTGF expression was not detected.

Conclusion. We postulate that gremlin may play a role in the fibrous process in crescentic nephritis, both in glomerular crescentic and tubular epithelial cells. The co-localization of gremlin and TGF-ß expression found in glomeruli and tubular cells suggest that gremlin may be important in mediating some of the pathological effects of TGF-ß.

Keywords: BMP-7 antagonist; crescentic glomerulonephritis; epithelial mesenchymal transition (EMT); gremlin; TGF-ß; Smad

Received for publication: 13. 9.06
Accepted in revised form: 23. 2.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
T. Turk, J. W. Leeuwis, J. Gray, S. V. Torti, K. M. Lyons, T. Q. Nguyen, and R. Goldschmeding
BMP Signaling and Podocyte Markers Are Decreased in Human Diabetic Nephropathy in Association With CTGF Overexpression
J. Histochem. Cytochem., July 1, 2009; 57(7): 623 - 631.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Roxburgh, J. J. Kattla, S. P. Curran, Y. M. O'Meara, C. A. Pollock, R. Goldschmeding, C. Godson, F. Martin, and D. P. Brazil
Allelic Depletion of grem1 Attenuates Diabetic Kidney Disease
Diabetes, July 1, 2009; 58(7): 1641 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Jara, C. Chacon, M. E. Burgos, A. Droguett, A. Valdivieso, M. Ortiz, P. Troncoso, and S. Mezzano
Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia
Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1121 - 1129.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.